ALS biotech says ice bucket challenge proceeds will pay for a new clinical trial

A local nonprofit biotech firm dedicated to finding treatments for ALS says it will use half of the $3 million it has received in donations in the past month to bring the second drug in its 15-year history to clinical trials two years earlier than it would have otherwise...